In this study, we hypothesized that a systematic analysis of gene expression alterations in brain samples obtained from postmortem AD and PSP patients, as well as amyloid and tau pathology animal models, could contribute to disentangle cellular processes affected at different stages of disease progression. This evidence concerns the gene MAPT and amyloidosis.